The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti–PD-1 immunotherapy with chemotherapy for poorly chemo-responsive thyroid and salivary gland tumors: The iPRIME study.
 
Faith Abodunrin
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Ari Rosenberg
Stock and Other Ownership Interests - Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Geovax Labs; Janssen; Nanobiotix; Novartis; RAPT Therapeutics; Regeneron; Summit Therapeutics; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Hookipa Biotech (Inst); Janux Therapeutics (Inst); Pfizer (Inst); Purple Biotech (Inst)
 
Jeffery Chin
No Relationships to Disclose
 
Rachel Hartnett
No Relationships to Disclose
 
Jeffrey Minehart
No Relationships to Disclose
 
Andrew Harding
No Relationships to Disclose
 
Aditya Juloori
Consulting or Advisory Role - AquaLung Therapeutics; AstraZeneca; DaiichiSanko; EMDSerrono; General Electric; GlaxoSmithKline; Isoray; Merck; Regeneron
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - EMD Serono
 
Chih-Yi Liao
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boston Scientific; Exelixis; Genentech; Histosonics; Incyte; Ipsen; Lexicon; Lilly; QED Therapeutics; Taiho Pharmaceutical; TransThera Biosciences
Speakers' Bureau - AstraZeneca; Eisai; Exelixis; Incyte
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Exelixis; Incyte; Ipsen
 
Rohan Katipally
No Relationships to Disclose
 
Sara Kochanny
No Relationships to Disclose
 
Nnamdi Omenuko
No Relationships to Disclose
 
Evgeny Izumchenko
No Relationships to Disclose
 
Nicole Cipriani
No Relationships to Disclose
 
Nishant Agrawal
Leadership - OrisDX
Stock and Other Ownership Interests - OrisDX; Privo Technologies
Speakers' Bureau - Merck
Patents, Royalties, Other Intellectual Property - Patent pending for salivary diagnostics to diagnose oral cancer.
 
Daniel Haraf
Patents, Royalties, Other Intellectual Property - UpToDate
 
Everett Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals; McKesson
Honoraria - Ascendis Pharma (I); Guidepoint Inc (I); Vision2Voice (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BioNTech SE; Boehringer Ingelheim; Day One Therapeutics; Delcath Systems; Eikon; EMD Serono; Foresight Diagnostics; Genmab; GlaxoSmithKline; Marengo Therapeutics; Merus; MJH Life Sciences; Translational Drug Development LLC
Research Funding - Abbvie; Alliance Pharma; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
 
Alexander Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics; Thermo Fisher Scientific
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences